Royal DSM, a global purpose-led science-based company, has recently announces the completion of the sale of its Engineering Materials business to Advent International and LANXESS for an Enterprise Value of €3.85 billion. The agreement was initially announced on 31 May 2022.
The transaction covers all of DSM’s Engineering Materials activities and marks the conclusion of DSM’s divestment of its Materials businesses in order to focus on Health and Nutrition. DSM anticipates a book profit on the sale of Engineering Materials of around €2.7 billion. DSM will receive approximately €3.5 billion net in cash.
